Topics
Glioblastoma | Treatment | Clinical trials | Proton Beam
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Proton Beam
Vora S, Pafundi D, Voss M, Buras M, Ashman J, Bendok B, Breen W,
Hu L, Kizilbash S, Laack N, Liu W, Mahajan A, Mrugala M, Porter A,
Ruff M, Sio T, Uhm J, Yang M, Brinkmann D, Brown P.
Short-course
hypofractionated proton beam therapy,
incorporating 18F-DOPA
PET and contrast-enhanced MRI
targeting, for patients aged 65 years
and older with newly diagnosed
glioblastoma: a single-arm phase 2
trial.
Lancet
Oncol. 2024 Nov 18:S1470-2045(24)00585-0. doi:
10.1016/S1470-2045(24)00585-0. PMID:
39571596. Interventional study˰
ˍ